ATE204840T1 - Verfahren zur herstellung von galanthaminderivate durch asymmetrische reduktion - Google Patents
Verfahren zur herstellung von galanthaminderivate durch asymmetrische reduktionInfo
- Publication number
- ATE204840T1 ATE204840T1 AT96909250T AT96909250T ATE204840T1 AT E204840 T1 ATE204840 T1 AT E204840T1 AT 96909250 T AT96909250 T AT 96909250T AT 96909250 T AT96909250 T AT 96909250T AT E204840 T1 ATE204840 T1 AT E204840T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- galanthamin
- derivatives
- producing
- asymmetric reduction
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 title 1
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9507100.7A GB9507100D0 (en) | 1995-04-06 | 1995-04-06 | Asymmetric reduction and products thereof |
| GBGB9601227.3A GB9601227D0 (en) | 1996-01-22 | 1996-01-22 | Reduction |
| PCT/GB1996/000843 WO1996031453A1 (en) | 1995-04-06 | 1996-04-04 | Process for preparing galanthamine derivatives by asymmetric reduction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE204840T1 true ATE204840T1 (de) | 2001-09-15 |
Family
ID=26306827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96909250T ATE204840T1 (de) | 1995-04-06 | 1996-04-04 | Verfahren zur herstellung von galanthaminderivate durch asymmetrische reduktion |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6018043A (de) |
| EP (1) | EP0819108B1 (de) |
| AT (1) | ATE204840T1 (de) |
| AU (1) | AU709080B2 (de) |
| CA (1) | CA2215518C (de) |
| CY (1) | CY2257B1 (de) |
| DE (1) | DE69614841T2 (de) |
| DK (1) | DK0819108T3 (de) |
| ES (1) | ES2162042T3 (de) |
| PT (1) | PT819108E (de) |
| TW (1) | TW448177B (de) |
| WO (1) | WO1996031453A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9506843D0 (en) * | 1995-04-03 | 1995-05-24 | Chiroscience Ltd | Oxidative process and products thereof |
| EP1670767B2 (de) * | 2003-09-26 | 2014-10-29 | ScinoPharm Taiwan, Ltd. | Optische trennung eines narwedinamidderivats |
| US20050142193A1 (en) * | 2003-12-31 | 2005-06-30 | Lijuan Tang | Galantamine formulations |
| CA2551946A1 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Immediate, controlled and sustained release formulations of galantamine |
| DE602006016441D1 (de) * | 2005-05-13 | 2010-10-07 | Alza Corp | Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss |
| WO2007035941A2 (en) * | 2005-09-23 | 2007-03-29 | Alza Corporation | Transdermal galantamine delivery system |
| CN100364995C (zh) * | 2006-01-12 | 2008-01-30 | 兰州大学 | 加兰它敏制备方法 |
| EP2009015B1 (de) | 2007-06-18 | 2012-01-11 | Aurobindo Pharma Limited | Herstellungsprozess für Galantaminhydrobromid |
| AT507039A1 (de) * | 2008-06-26 | 2010-01-15 | Sanochemia Pharmazeutika Ag | Verfahren zum herstellen von hochreinen benzazepinderivaten |
| CN102180886B (zh) * | 2011-03-05 | 2015-01-21 | 兰州大学 | 加兰他敏不对称催化合成方法 |
-
1996
- 1996-04-04 US US08/930,211 patent/US6018043A/en not_active Expired - Lifetime
- 1996-04-04 AU AU52819/96A patent/AU709080B2/en not_active Expired
- 1996-04-04 CA CA002215518A patent/CA2215518C/en not_active Expired - Lifetime
- 1996-04-04 DE DE69614841T patent/DE69614841T2/de not_active Expired - Lifetime
- 1996-04-04 WO PCT/GB1996/000843 patent/WO1996031453A1/en not_active Ceased
- 1996-04-04 ES ES96909250T patent/ES2162042T3/es not_active Expired - Lifetime
- 1996-04-04 EP EP96909250A patent/EP0819108B1/de not_active Expired - Lifetime
- 1996-04-04 AT AT96909250T patent/ATE204840T1/de active
- 1996-04-04 PT PT96909250T patent/PT819108E/pt unknown
- 1996-04-04 DK DK96909250T patent/DK0819108T3/da active
- 1996-04-19 TW TW085104664A patent/TW448177B/zh not_active IP Right Cessation
-
2002
- 2002-01-04 CY CY0200005A patent/CY2257B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU5281996A (en) | 1996-10-23 |
| DE69614841D1 (de) | 2001-10-04 |
| DE69614841T2 (de) | 2002-04-11 |
| CA2215518A1 (en) | 1996-10-10 |
| CA2215518C (en) | 2006-11-28 |
| PT819108E (pt) | 2002-02-28 |
| CY2257B1 (en) | 2003-07-04 |
| TW448177B (en) | 2001-08-01 |
| EP0819108B1 (de) | 2001-08-29 |
| AU709080B2 (en) | 1999-08-19 |
| DK0819108T3 (da) | 2001-11-26 |
| WO1996031453A1 (en) | 1996-10-10 |
| US6018043A (en) | 2000-01-25 |
| ES2162042T3 (es) | 2001-12-16 |
| EP0819108A1 (de) | 1998-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69722027D1 (de) | Kristalle von benzimidazolderivate und verfahren zu ihrer herstellung | |
| DE69711391D1 (de) | Verbessertes verfahren zum herstellen von geschützten 3,4-dihydroxybuttersäure estern | |
| DE59603876D1 (de) | Verfahren zur herstellung von chinazolinderivaten | |
| ATE204840T1 (de) | Verfahren zur herstellung von galanthaminderivate durch asymmetrische reduktion | |
| ATE172198T1 (de) | Verfahren zur herstellung von n-acetyl- neuraminsäurederivaten | |
| ATE204861T1 (de) | Verfahren zur herstellung von 2,2'-bipyrrolyl- pyrromethen-derivaten (prodigiosine) | |
| ATE239701T1 (de) | Polyethoxylierte retinamid-derivate und verfahren zu ihrer herstellung | |
| ATE261944T1 (de) | Verfahren zur herstellung von carbamoylsubstituierten imidazolderivaten | |
| ATE301659T1 (de) | Verfahren zur herstellung von campothecinderivate | |
| DE69719511D1 (de) | Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung | |
| ATE174602T1 (de) | Verfahren zur herstellung von kristallen des wachstumshormones und die so erhaltenen kristalle | |
| ATE189219T1 (de) | Verfahren zur herstellung von liponsaeure | |
| DE60104704D1 (de) | Verfahren zur herstellung einer substituierten imidazopyridinverbindung | |
| DE69718925D1 (de) | Verfahren zur herstellung von n-[2-(dimethylamino)ethyl]akridin-4-carbonsäureamide | |
| ATE188694T1 (de) | Verfahren zur herstellung von benzopyranderivaten | |
| ATE195115T1 (de) | Verfahren zur herstellung von 5,6-dihydroxy-2- amino-1,2,3,4-tetrahydronaphthalin-derivaten | |
| ATE217316T1 (de) | Verfahren zur herstellung von diphosphonat- derivaten | |
| DE69504188D1 (de) | Verfahren zur herstellung von 5-amino-1,3-dioxanen | |
| ATE143965T1 (de) | Verfahren zur herstellung von derivaten der bis(aminomethyl)phosphinsäure | |
| ATE161529T1 (de) | Verfahren zur herstellung von 6-aryloxymethyl-1- hydroxy-4-methyl-2-pyridonen | |
| DE69310369D1 (de) | Verfahren zur herstellung von 3,3-diarylacrylsäureamiden | |
| DE60321577D1 (de) | Verfahren zu deren herstellung | |
| DE69209094D1 (de) | Verfahren zur herstellung von 2-amino-7-nitrobenzothiazolen | |
| ATE215071T1 (de) | Verfahren zur herstellung von prostaglandin e1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |